Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 4231 AL 4245

Beam Walking to Assess Dynamic Balance in Health and Disease: A Protocol for the "BEAM" Multicenter Observational Study

Hortobágyi T, Uematsu A, Sanders L, Kliegl R, Tollár J, Moraes R, Granacher U.

Gerontology. 2019;65(4):332-339. doi: 10.1159/000493360. Epub 2018 Oct 18.

Neurotransmitter trafficking defect in a patient with clathrin (CLTC) variation presenting with intellectual disability and early-onset parkinsonism

Manti F, Nardecchia F, Barresi S, Venditti M, Pizzi S, Hamdan FF, Blau N, Burlina A, Tartaglia M, Leuzzi V.

Parkinsonism Relat Disord. 2019 Apr;61:207-210. doi: 10.1016/j.parkreldis.2018.10.012. Epub 2018 Oct 11.

Pseudo-orthostatic tremor in idiopathic Parkinson's disease: could it be re-emergent tremor?

Yoo SW, Choi KE, So J, Lee KS, Kim JS.

Neurol Sci. 2019 Mar;40(3):621-623. doi: 10.1007/s10072-018-3605-x. Epub 2018 Oct 18.

Role of GTPases in the Regulation of Mitochondrial Dynamics in Alzheimer's Disease and CNS-Related Disorders

Alexiou A, Soursou G, Chatzichronis S, Gasparatos E, Kamal MA, Yarla NS, Perveen A, Barreto GE, Ashraf GM.

Mol Neurobiol. 2019 Jun;56(6):4530-4538. doi: 10.1007/s12035-018-1397-x. Epub 2018 Oct 18.

The power of the Parkinson's patient according to Tom Isaacs: a call to action

Mathur S.

Eur J Neurosci. 2019 Feb;49(3):304-306. doi: 10.1111/ejn.14211. Epub 2018 Nov 9.

No evidence for DNM3 as genetic modifier of age at onset in idiopathic Parkinson's disease

Berge-Seidl V, Pihlstrøm L, Wszolek ZK, Ross OA, Toft M.

Neurobiol Aging. 2019 Feb;74:236.e1-236.e5. doi: 10.1016/j.neurobiolaging.2018.09.022. Epub 2018 Sep 22.

Validation of the utility of the Brief Smell Identification Test in Chinese patients with Parkinson's disease

Cao M, Li Y, Gu Z, Mi T, Xu X, Ma C, Chen M, Wu M, Chan P.

J Clin Neurosci. 2019 Feb;60:68-72. doi: 10.1016/j.jocn.2018.10.023. Epub 2018 Oct 16.

Simultaneous determination of FLZ and its metabolite (M1) in human plasma and urine by UHPLC-MS/MS: Application to a pharmacokinetic study

Cui C, Chen R, Jiang J, Liu R, Wang W, Zhao Q, Hu P.

J Pharm Biomed Anal. 2019 Feb 5;164:32-40. doi: 10.1016/j.jpba.2018.10.018. Epub 2018 Oct 10.

Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis

Johnson ME, Stecher B, Labrie V, Brundin L, Brundin P.

Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.

An outline for the pharmacological effect of icariin in the nervous system

Jin J, Wang H, Hua X, Chen D, Huang C, Chen Z.

Eur J Pharmacol. 2019 Jan 5;842:20-32. doi: 10.1016/j.ejphar.2018.10.006. Epub 2018 Oct 19.

Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease

Chen W, Huang Q, Ma S, Li M.

ACS Chem Neurosci. 2019 Feb 20;10(2):839-851. doi: 10.1021/acschemneuro.8b00389. Epub 2018 Oct 24.

Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease

Fabbri M, Zibetti M, Beccaria L, Merola A, Romagnolo A, Montanaro E, Ferreira JJ, Palermo S, Lopiano L.

Eur J Neurol. 2019 Mar;26(3):490-496. doi: 10.1111/ene.13844. Epub 2018 Nov 18.

Latency of re-emergent tremor in Parkinson's disease is influenced by levodopa

Wilken M, Rossi MD, Rivero AD, Hallett M, Merello M.

Parkinsonism Relat Disord. 2019 Apr;61:166-169. doi: 10.1016/j.parkreldis.2018.10.019. Epub 2018 Oct 15.

Mathematical Biology Models of Parkinson's Disease

Bakshi S, Chelliah V, Chen C, van der Graaf PH.

CPT Pharmacometrics Syst Pharmacol. 2019 Feb;8(2):77-86. doi: 10.1002/psp4.12362. Epub 2018 Nov 2.

Pharmacogenetics and levodopa induced motor complications

Kalinderi K, Papaliagkas V, Fidani L.

Int J Neurosci. 2019 Apr;129(4):384-392. doi: 10.1080/00207454.2018.1538993. Epub 2018 Dec 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias